Windhover Information Makes Investment in MarketMonitors; New Pipeline R&D Database Service Will Be Launched at Windhover and Medtech Insight’s In3 WEST Conference on February 23-24 in Irvine, CA

NORWALK, CT—Feb. 7, 2006—Windhover Information Inc., a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries, has announced a strategic investment in MarketMonitors, Inc. (MMI), a provider of online business intelligence databases with customized analytic features to the medical device and biologics industries.

MMI has developed a suite of comprehensive, highly searchable, up-to-date electronic databases designed specifically for use by executives in the medical technology and investment industry. The first product to be launched is Pipeline, an online database service that continuously tracks the status and progress of technologies in R&D, by both major medical device firms as well as the large number of privately held, small start-up companies who are typically the innovators in medical technology development. Pipeline is a productivity tool that systematically collects, organizes, and synthesizes an enormous volume of constantly changing data and information about new technologies in development.

The primary focus of Pipeline is on breakthrough, investigational medical devices, combination therapies, and biologics in active development and intended for the U.S. marketplace. The database provides highly structured access to the details of new product development, including technology, target markets, clinical testing, FDA status, patents, and many other key dimensions of competitive information. 

In addition, in-depth profiles of market strategy, management team, scientific advisory board, and funding history are provided for those early-stage startup companies. Pipeline’s classification and interactive filtering system facilitates easy identification of competing products. Drill-down and rollup tools provide speedy transition between detailed product information and high-level summaries across products, companies, or technologies.

The first Pipeline product is cvPipeline, which tracks the R&D landscape for the cardiovascular market. Currently available in cvPipeline are three sectors: Atrial Fibrillation, Heart Failure, and Heart Valves. Three additional sectors in development are Coronary Stents, Regenerative Medicine, and PFO Technologies. The electronic platform will be expanded in the future to other high-growth segments of the medtech and biologics industries, including neuro, regenerative medicine, spine/orthopedics, and ophthalmology, among others. For a tour of cvPipeline, along with features and sector coverage, please visit www.cvpipeline.com.

MMI has also announced that it will be launching cvPipeline at a presentation on Thursday, February 23, 2006, at Medtech Insight and Windhover Information's "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" Conference, being held February 23-24, 2006 at the Hyatt Regency Irvine in Irvine, California (for event details, visit www.medtechinsight.com/in3-16.html).

MMI’s board of directors includes David Cassak, Managing Director of Windhover Information; Sharon O’Reilly, Founder of Medtech Insight; and Hollis Call, who is President & CEO of the company and was formerly a co-founder of MD-DATA DIRECT. The MMI Editorial Staff is headed by Minda Lehto, formerly Managing Editor of MedPro Month and a writer for Medtech Insight and The Gray Sheet. Marketing and Business Development is under the direction of Eric Lehto, whose information services and healthcare background includes positions at McKesson and Medical Data International. MMI Chief Technology Officer Michael Mazour has held management positions with Sun Microsystems and Apple Computer.

“MarketMonitors’ platform is systematic, comprehensive, timely, and easy to use, and sets a new standard for medical industry market intelligence,” says Sharon O’Reilly, former President & CEO of Medtech Insight, which was acquired by Windhover in 2004. “It’s designed specifically for how industry executives work today.”

“Pipeline brings a new level of functionality and usability to medical business information,” says David Cassak, Managing Director of Windhover Information. “With its sophisticated tools, up-to-date content, and ability to track changes in the R&D landscape, Pipeline will revolutionize the way due diligence is done.”

About MarketMonitors, Inc.

MarketMonitors, Inc. (MMI) (www.marketmonitors.com) is a provider of online business intelligence databases with customized analytic features to the medical device and biologics industries. In addition to Pipeline, the company has developed other online services, including customized access to large-volume medical claims data for market analysis and sales force support.

CONTACT: Hollis Call, MarketMonitors President and CEO: 650.331.0001; hcall@marketmonitors.com; www.marketmonitors.com